Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CN-CATCH: CN-105 in Acute Supratentorial Intracerebral Hemorrhage
NCT06255977Phase 2Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Aug 2022
- Primary completion
- May 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CN-105 in intracerebral hemorrhage (ICH), sponsored by Beijing Tiantan Hospital. Started Aug 2022; status: recruiting.
02
Drugs
CN-105
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT06255977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06255977.